SHPH Q4 2024 Earnings — Shuttle Pharmaceuticals Holdings, Inc. Revenue & Financial Results | Market Cap Arena

SHPHShuttle Pharmaceuticals Holdings, Inc.

$1M

Q4 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$1,796

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.55

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$31,858

Balance Sheet

Total Assets

$3M

Total Liabilities

$2M

Stockholders' Equity

$709,152

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,796	-$1,983	+9.4%
Operating Income	-$2M	-$1M	-38.5%
Net Income	-$2M	-$2M	+2.6%